Exact Mass: 240.1438
Exact Mass Matches: 240.1438
Found 196 metabolites which its exact mass value is equals to given mass value 240.1438,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Pirbuterol
Pirbuterol is a beta-2 adrenergic bronchodilator. In vitro studies and in vivo pharmacologic studies have demonstrated that pirbuterol has a preferential effect on beta-2 Adrenergic receptors compared with isoproterenol. While it is recognized that beta-2 adrenergic receptors are the predominant receptors in bronchial smooth muscle, data indicate that there is a population of beta-2 receptors in the human heart, existing in a concentration between 10-50\\%. The precise function of these receptors has not been established. The pharmacologic effects of beta adrenergic agonist drugs, including pirbuterol, are at least in proof attributable to stimulation through beta adrenergic receptors of intracellular adenyl cyclase, the enzyme which catalyzes the conversion of adenosine triphosphate (AlP) to cyclic-3†,5†-adenosine monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
Imiquimod
Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment. Imiquimod does not fight the viruses that cause warts directly, however, it does help to relieve and control wart production. miquimod is also used to treat a skin condition of the face and scalp called actinic keratoses and certain types of skin cancer called superficial basal cell carcinoma. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D007155 - Immunologic Factors > D007369 - Interferon Inducers D000970 - Antineoplastic Agents C274 - Antineoplastic Agent
Bicyclo[2.2.1]heptan-2-one, 1,7,7-trimethyl-3-(phenylmethylene)-
trans-9-hydroxy-3-methyl-8-oxo-dodec-trans-6-en-4-olide
heptadeca-1,9t-diene-11,13,15-triyn-8-ol|trans-Heptadecadien-(1.9)-triin-(11.13.15)-ol-(8)
(5E,7E,9Z,15E)-5,7,9,15-Heptadecatetraene-11,13-diyn-4-ol
(-)-12-hydroxyjasmonic acid methyl ester|(-)-methyl 12-hydroxyjasmonate|(1R,2R)-Methyl-5-hydroxyjasmonate|5-hydroxyjasmonic acid methyl ester|methyl (1R,2R)-5-hydroxyjasmonate|methyl (1S,2R,2Z)-2-(5-hydroxy-2-pentenyl)-3-oxo-cyclopentaneacetate
7,8-Epoxide-(E,E,E)-1,7,9,15-Heptadecatetraene-11,13-diyne|hepta-deca-1,9E,15E-trien-11,13-diyn-7,8-epoxide
(all-E)-1,7,9,15-Heptadecatetraene-11,13-diyn-6-ol
(R)-4-isopropenyl-3-methoxy-1-(3-methyl-2-oxo-butyl)-imidazolidin-2-one|Alchorneinon|Alchorneinone
(2beta,3beta,5alpha,6alpha,7E)-5,6-Epoxy-2,3-dihydroxy-7-megastigmen-9-one
(3R)-heptadeca-1,9(Z),11(Z),16-tetraene-4,6-diyne-3-ol|didehydrofalcarinol
7,9,15-Heptodecatriene-11,13-diynal|heptadeca-7t,9t,15t-triene-11,13-diynal
2-methylidenepropane-1,3-diyl 1-((Z)-2-methyl-2-butenoate) 3-isobutyrate
(1RS,9RS)-3-hydroxymethyl-8Z-(2E-pentenyliden)-2,6-dioxa-spiro<4.4>nonanol-9|(1RS,9RS)-3-hydroxymethyl-8Z-(2E-pentenyliden)-2,6-dioxa-spiro[4.4]nonanol-9|9-Hydroxy-8-(2-pentenylidene)-1,6-dioxaspiro[4,4]nonane-2-methanol
(E)-1,8,16-Heptadecatriene-4,6-diyn-3-one|heptadeca-1,8t,16-triene-4,6-diyn-3-one
methyl (2Z,4E)-3-methoxycarbonyl-2-methyl-2,4-nonadienoate
(E)-4-((rel-3R,4S,6R)-4-hydroxy-4-methyl-6-(2-oxopropyl)-tetrahydro-2H-pyran-3-yl)but-3-en-2-one|quamopyran
(6S,7R,8R,9S)-6-oxaspiro-7,8-dihydroxymegastigman-4-en-3-one|tubiflorone
6-hexyl-3-methyl-(3S,3aS,6R,6aR)-perhydrofuro[3,4-b]furan-2,4-dione
(all-E)-1,4,8,10,16-Heptadecapentaen-6-yn-3-one|heptadeca-1,4t,8t,10t,16-pentaen-6-yn-3-one|Heptadeca-pentaen-(1,4t,8t,10t,16)-in-(6)-on-(3)
(2E,8E,10E)-heptadeca-2,8,10-triene-4,6-diyn-1-al|all-trans-Heptadecatrien-(2.8.10)-diin-(4.6)-al|enanthetal|heptadeca-2t,8t,10t-triene-4,6-diynal|oenanthetal
1, 2-Dihydroxy-Flavacol|1-hydroxy-6-(2-hydroxy-2-methyl-propyl)-3-isobutyl-1H-pyrazin-2-one|beta-Hydroxyneoaspergillinsaeure
enanthetone|Heptadeca-7t,9t,15t-trien-11,13-diin-4-on|heptadeca-7t,9t,15t-triene-11,13-diyn-4-one|Oenantheton|oenanthetone
imiquimod
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use > D06BB - Antivirals C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D007155 - Immunologic Factors > D007369 - Interferon Inducers D000970 - Antineoplastic Agents C274 - Antineoplastic Agent
diethyldiallylmalonate
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1054
tetrabarbital
C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C67084 - Barbiturate
METHYL 7-(3-HYDROXY-5-OXOCYCLOPENT-1-EN-1-YL)HEPTANOATE
tert-butyl 8-oxo-2,7-diazaspiro[4.4]nonane-2-carboxylate
2-Methyl-2-propanyl 4-cyano-4-methoxy-1-piperidinecarboxylate
3-Benzylidene camphor
D020011 - Protective Agents > D011837 - Radiation-Protective Agents > D013473 - Sunscreening Agents D003879 - Dermatologic Agents D003358 - Cosmetics
lithium,2-[(4-methylpiperazin-1-yl)methyl]benzoate
3-(4-hydroxypiperidine-1-carbonyl)piperidine-1-carbaldehyde
METHYL (R)-(+)-3-HYDROXY-5-OXO-1-CYCLOPENTENE-1-HEPTANOATE
Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate
tert-Butyl 4-(cyanomethyl)-4-hydroxypiperidine-1-carboxylate
2-Methyl-2-propanyl 4-cyano-4-(hydroxymethyl)-1-piperidinecarboxylate
Propanedioic acid,2-(2-cyclohexen-1-yl)-, 1,3-diethyl ester
tert-butyl 2-oxo-1,7-diazaspiro[3.5]nonane-7-carboxylate
TERT-BUTYL 2,7-DIAZASPIRO[3.5]NONANE-7-CARBOXYLATE HYDROCHLORIDE
tert-Butyl 2-oxo-1,7-diazaspiro[4.4]nonane-7-carboxylate
3-(HYDROXYIMINO)-8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXYLICACID1,1-DIMETHYLETHYLESTER
methyl 7-[(3S)-3-hydroxy-5-oxocyclopenten-1-yl]heptanoate
tert-Butyl 3-((dimethylamino)methylene)-4-oxopyrrolidine-1-carboxylate
Buterazine
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
TERT-BUTYL 6-OXO-2,7-DIAZASPIRO[4.4]NONANE-2-CARBOXYLATE
3-[(3aS,4S,5R,7aS)-5-hydroxy-7a-methyl-1,5-dioxo-octahydroinden-4-yl]propanoic acid
2-[(6R)-6-hydroxy-6-methyl-5-oxooctyl]-2H-furan-5-one
[(1S)-6-acetamido-1,2,3,5,6,7,8,8a-octahydroindolizin-1-yl] acetate
Methyl (1S,2R,(4A)R,8S,(8A)R)-1,2,3,5,6,7,8,(8A)-octahydro-8-hydroxy-2-methylnaphthalen-4(4A)H)-one-1-carboxylate
PIRBUTEROL
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
3-[(3aS,4S,5R,7aS)-5-hydroxy-7a-methyl-1-oxo-octahydroinden-4-yl]propanoic acid
A dioxo monocarboxylic acid that consists of hydrindane bearing oxo and hydroxy substituents at positions 1 and 5 respectively as well as a 2-carboxyethyl substituent at position 4 (the 3aS,4S,5R,7aS diastereomer).
2-[(3s,5r)-5-hexyl-2-oxooxolan-3-yl]prop-2-enoic acid
(3z,4s,5r,7r)-7-(hydroxymethyl)-3-[(2e)-pent-2-en-1-ylidene]-1,6-dioxaspiro[4.4]nonan-4-ol
(1s,5s,8s)-8-hydroxy-8-[(1e)-3-hydroxybut-1-en-1-yl]-1,5-dimethyl-6-oxabicyclo[3.2.1]octan-3-one
n-[(1s)-1-(acetyloxy)-octahydroindolizin-6-yl]ethanimidic acid
(5s)-5-(6-hydroxy-6-methyl-5-oxooctyl)-5h-furan-2-one
(2e,8z,10e)-heptadeca-2,8,10,16-tetraen-4,6-diyn-1-ol
(4-methylidene-5-oxooxolan-3-yl)methyl 5-methylhexanoate
1-hydroxy-6-methoxy-3-(2-methylpropyl)-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one
(2z,4e,8e,10e)-heptadeca-2,4,8,10,16-pentaen-6-ynal
(2r,3r)-2-(hex-5-en-1-yl)-3-[(1e,7e)-nona-1,7-dien-3,5-diyn-1-yl]oxirane
1,4-dimethyl 2-(hex-1-en-1-yl)-3-methylbut-2-enedioate
13-carboxy-blumenol c
{"Ingredient_id": "HBIN001151","Ingredient_name": "13-carboxy-blumenol c","Alias": "NA","Ingredient_formula": "C13H20O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3165","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
apocynol b
{"Ingredient_id": "HBIN016507","Ingredient_name": "apocynol b","Alias": "NA","Ingredient_formula": "C13H20O4","Ingredient_Smile": "CC(C=CC1(C(=CC(=O)CC1(C)C)CO)O)O","Ingredient_weight": "240.29 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1528","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10977562","DrugBank_id": "NA"}
